Jia Jie Biomedical Co Ltd (4109) — Cash Flow Quality Index
Jia Jie Biomedical Co Ltd (4109) has a Cash Flow Quality Index of 0.70x as of March 2026. Operating cash flow of NT$12.96 Million is below net income of NT$18.40 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 4109 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jia Jie Biomedical Co Ltd Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Jia Jie Biomedical Co Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 4109 operating cash flow.
Annual Cash Flow Quality Index for Jia Jie Biomedical Co Ltd (2015–2025)
Year-by-year earnings quality comparison for Jia Jie Biomedical Co Ltd.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.42x | NT$21.34 Million | NT$50.26 Million | ▲ +102.4% |
| 2024 | 0.21x | NT$44.35 Million | NT$211.37 Million | ▲ +785.1% |
| 2023 | -0.03x | NT$-4.49 Million | NT$146.55 Million | ▼ -103.7% |
| 2021 | 0.83x | NT$4.37 Million | NT$5.29 Million | ▲ +115.6% |
| 2018 | -5.29x | NT$-13.10 Million | NT$2.47 Million | ▲ +19.6% |
| 2016 | -6.58x | NT$-76.54 Million | NT$11.63 Million | ▼ -402.9% |
| 2015 | 2.17x | NT$82.22 Million | NT$37.84 Million | — |